Patents Assigned to Cognigenics, Inc.
  • Methods for sustainable human cognitive enhancement
    Publication number: 20210393796
    Abstract: A method of achieving sustainable, general-purpose cognitive enhancement comprising administering a gene-editing endonuclease complexed with a neuron-targeting vector and a synthetic guide RNA to lower the population of 5-hydroxytryptamine 2A receptors in the brain.
    Type: Application
    Filed: February 10, 2021
    Publication date: December 23, 2021
    Applicant: Cognigenics, Inc.
    Inventor: John Lawrence Mee